About
Caspr Biotech was a startup focused on developing portable, rapid, and affordable diagnostic kits using CRISPR technology. Their solutions aimed to detect infectious diseases and antimicrobial resistance in clinics and hospitals, providing faster and more accurate results than traditional methods. The company's technology leveraged novel Cas enzymes discovered in extreme environments.
Listed competitors
Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
Leveraging the adaptive immune system to diagnose and treat disease.
Also in this space
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Shares Biotech, HealthTech
Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.
Shares Biotech, Synthetic Biology
Vexxel is developing a novel platform for cell-free protein synthesis and engineering.
Shares Biotech, MedTech
Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.
Shares Biotech, Drug Discovery
SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.
Shares Biotech, MedTech
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Shares Biotech, HealthTech
Key facts
- Website
- casprbio.com
- Headquarters
- Buenos Aires, Argentina
- Business model
- B2B
Tech stack
Detected on casprbio.com, last scanned 21 Jul 2026. Run your own scan
- SEO
- Rank Math
- CMS / Builders
- WordPress
Caspr Biotech scores 22. Does yours?
That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.
Frequently asked
What is Caspr Biotech's current status?
Caspr Biotech's current operating status is: Inactive.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Caspr Biotech
